Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Open access

A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants

Diwakar Rathour Shweta Shrivas Naresh Kumar Chaman Prasad Janmejay Singh G. Singh A. Surendranath Shweta Rathi Sneha Verma Supriya Chauhan Balwant Singh Jyoti Sutar S. Chattopadhyay G. Batra Sudipta Sonar Isabella Eckerle Lorenzo Subbissi A. Mohan Shailendra Asthana Suprit Deshpande Jayanta Bhattacharya
Jul 2026 · bioRxiv · 0 citations · 25 references
Biology

TL;DR

It is found that among individuals with hybrid immunity who developed robust, durable antigen-specific antibody responses, one developed antibody response capable of broadly cross-neutralising contemporary Omicron variants.

DOI Semantic Scholar
Read PDF

Similar papers

Open access Sep 2026

Immunogen selection and prior immunity shape antibody breadth following immunisation with avian H5 hemagglutinin

A considerable variability in the potential of H5 vaccine antigens to induce neutralisation breadth is demonstrated, as well as the potential for multivalent vaccines and ferritin nanoparticle-based strategies to robustly augment immunity across antigenic variants.

Yee-Chen Liu, Andrew Kelly, R. Esterbauer et al. · 0 citations
Open access Sep 2026

A dimeric mRNA vaccine based on key-mutant and KP.3 RBDs induces broad-spectrum immunity and protects mice against JN.1 and XDV challenges

The continued antigenic evolution of SARS-CoV-2 Omicron subvariants has progressively eroded vaccine-elicited protective immunity, driving demand for next-generation candidates that confer broad-spectrum protection against phylogenetically divergent strains. Here we report the design and preclinical evaluation of SV, a...

Jia-Li Xu, Rui Peng, Long-Hai Yuan et al. · 0 citations
Aug 2026

Convergent IGHV3-53/3-66 antibodies elicited by Omicron BA.1 infection broadly neutralize emerging SARS-CoV-2 variants

G germline revertant analysis of the COV2-3731 mAb provided additional insights into how this COV2-3731 and other IGHV3-53/3-66-encoded public antibodies evolve to gain breadth against antigenically distinct SARS-CoV-2 variants such as BA.2.3.2, BA.3.1, KP.2.2, and, to some extent, KP.3.3.2.

Naveenchandra Suryadevara, Seth J. Zost, John M. Powers et al. · 0 citations
Open access Aug 2026

Cross-Neutralizing Antibody Responses to Diverse Coronaviruses in the Human Population.

It is demonstrated that post-pandemic sera exhibit enhanced cross-neutralizing antibody responses predominantly against sarbecoviruses, potentially strengthening population immunity against related zoonotic sarbecoviruses and increasing the immunological barrier to their emergence in humans.

Shixiong Zhou, Chun-Hai Liu, Weiyong Liu et al. · 0 citations
Open access Jul 2026

Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort.

The observed waning of cross-neutralizing antibodies against emerging variants underscores the challenge of maintaining durable protection and supports the need for continued monitoring of antibody responses to guide evidence-based updates to COVID-19 vaccines.

Wei Wang, E. Goguet, Sabrina Lusvarghi et al. · 0 citations
Jul 2026

Complement augments antibody neutralization of SARS-CoV-2 variants.

The data show that complement potentiates the ability of antispike antibodies to neutralize immune-evasive SARS-CoV-2 variants and in sera from individuals with severe COVID-19, both complement-mediated neutralization and anti-S2 antibody levels were associated with improved survival.

M. Jungbauer-Groznica, Pierre Rosenbaum, I. Staropoli et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.